Clinical trial
Safety, Tolerability and Efficacy of the Transdermal System in Elderly Subjects…
NCT00285766 · Somerset Pharmaceuticals, Industry · Completed
Key facts
| NCT number | NCT00285766 |
|---|---|
| Title | Safety, Tolerability and Efficacy of the Transdermal System in Elderly Subjects With Major Depression |
| Official title | A Phase III, Open-Label Study of the Safety, Tolerability and Efficacy of the Selegiline Transdermal System in Elderly Subjects With Major Depression |
| Lead sponsor | Somerset Pharmaceuticals, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Major Depression |
| Intervention type | Drug |
| Interventions | Selegiline Transdermal System |
| Enrollment | 300 |
| Start date | Aug 1, 2002 |
| Completion | Jul 1, 2005 |
| First posted | Feb 2, 2006 |
| Last update posted | Apr 22, 2008 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: